Combination Therapy Boosts Lung Cancer Patients’ Response, Cuts Treatment Time

Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in patients with early-stage, non-small-cell lung cancer.